CRISPR Therapeutics Cash from Investing (TTM)

CRISPR Therapeutics AG (CRSP)

45.18

+1.33 (+3.03%) USD | NASDAQ | Mar 29, 16:00

45.30

+0.12 (+0.27%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2022	-258.66M
September 30, 2022	-91.84M
June 30, 2022	-744.48M
March 31, 2022	-982.05M
December 31, 2021	-1.035B
September 30, 2021	-1.231B
June 30, 2021	-996.11M
March 31, 2021	-706.08M
December 31, 2020	-541.17M
September 30, 2020	-329.87M
June 30, 2020	-2.00M
March 31, 2020	-0.569M
December 31, 2019	1.325M

Date	Value
September 30, 2019	-6.732M
June 30, 2019	-4.966M
March 31, 2019	-3.315M
December 31, 2018	-2.773M
September 30, 2018	-1.978M
June 30, 2018	-4.777M
March 31, 2018	-5.584M
December 31, 2017	-8.314M
September 30, 2017	6.663M
June 30, 2017	8.648M
March 31, 2017	8.931M
December 31, 2016	31.88M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-1.231B

Minimum

Sep 2021

1.325M

Maximum

Dec 2019

-347.40M

Average

-49.29M

Median

Cash from Investing (TTM) Benchmarks